Jiaming Lan

1.1k total citations
37 papers, 576 citations indexed

About

Jiaming Lan is a scholar working on Infectious Diseases, Animal Science and Zoology and Epidemiology. According to data from OpenAlex, Jiaming Lan has authored 37 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 10 papers in Animal Science and Zoology and 8 papers in Epidemiology. Recurrent topics in Jiaming Lan's work include SARS-CoV-2 and COVID-19 Research (18 papers), Viral gastroenteritis research and epidemiology (11 papers) and Animal Virus Infections Studies (10 papers). Jiaming Lan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (18 papers), Viral gastroenteritis research and epidemiology (11 papers) and Animal Virus Infections Studies (10 papers). Jiaming Lan collaborates with scholars based in China, Canada and France. Jiaming Lan's co-authors include Yao Deng, Wenjie Tan, George F. Gao, Zhuozhuang Lu, Hong Chen, Guangwen Lu, Yanfeng Yao, Gary Wong, Chuan Qin and Linlin Bao and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Controlled Release.

In The Last Decade

Jiaming Lan

34 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiaming Lan China 13 464 187 86 78 69 37 576
Meagan Bolles United States 6 600 1.3× 188 1.0× 112 1.3× 83 1.1× 92 1.3× 7 695
Shaofeng Deng China 10 360 0.8× 100 0.5× 100 1.2× 77 1.0× 65 0.9× 21 501
Prudence Kgagudi South Africa 7 685 1.5× 108 0.6× 185 2.2× 92 1.2× 69 1.0× 10 797
Eun Kim United States 6 340 0.7× 78 0.4× 81 0.9× 90 1.2× 92 1.3× 16 567
Michael T. Boswell South Africa 8 679 1.5× 108 0.6× 184 2.1× 46 0.6× 71 1.0× 11 751
Panke Qu United States 15 664 1.4× 121 0.6× 215 2.5× 90 1.2× 62 0.9× 15 740
Brent Oosthuysen South Africa 3 617 1.3× 103 0.6× 173 2.0× 36 0.5× 60 0.9× 4 678
Frances Ayres South Africa 5 660 1.4× 110 0.6× 181 2.1× 42 0.5× 79 1.1× 8 729
Martin Müller Germany 8 585 1.3× 98 0.5× 174 2.0× 137 1.8× 120 1.7× 12 764

Countries citing papers authored by Jiaming Lan

Since Specialization
Citations

This map shows the geographic impact of Jiaming Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaming Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaming Lan more than expected).

Fields of papers citing papers by Jiaming Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaming Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaming Lan. The network helps show where Jiaming Lan may publish in the future.

Co-authorship network of co-authors of Jiaming Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaming Lan. A scholar is included among the top collaborators of Jiaming Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaming Lan. Jiaming Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lan, Jiaming, Xin He, Jin Sun, et al.. (2025). Nanomedicines as disruptors or inhibitors of biofilms: Opportunities in addressing antimicrobial resistance. Journal of Controlled Release. 381. 113589–113589. 13 indexed citations
2.
Yao, Yanfeng, Yun Peng, Xuejie Li, et al.. (2025). Single-dose intranasal AdC68-vectored vaccines rapidly protect Syrian hamsters against lethal Nipah virus infection. Molecular Therapy. 33(7). 3270–3285.
3.
Lan, Jiaming, et al.. (2025). Advancements in dengue vaccines: A historical overview and pro-spects for following next-generation candidates. The Journal of Microbiology. 63(2). e2410018–e2410018. 5 indexed citations
4.
Wu, Yi, Xiaoying Jia, Xinghai Zhang, et al.. (2024). Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants. Acta Pharmaceutica Sinica B. 15(2). 947–962.
5.
Chen, Tong, Zhe Ding, Xuejie Li, et al.. (2024). A mRNA Vaccine for Crimean–Congo Hemorrhagic Fever Virus Expressing Non-Fusion GnGc Using NSm Linker Elicits Unexpected Immune Responses in Mice. Viruses. 16(3). 378–378. 3 indexed citations
6.
Zhang, Houjun, Xuejie Li, Haonan Cheng, et al.. (2024). Synthesis, Reaction Mechanism, DNA Cleavage, and Antitumor Properties of Pyridazinedione‐Fused Enediynes. ChemistrySelect. 9(39). 2 indexed citations
7.
Li, Ruiya, Xing Chen, Yanhua Chen, et al.. (2023). Virome characterization and identification of a putative parvovirus and poxvirus in bat ectoparasites of Yunnan Province, China. One Health. 17. 100641–100641. 1 indexed citations
8.
Chen, Tong, Zhe Ding, Jiaming Lan, & Gary Wong. (2023). Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses. Frontiers in Cellular and Infection Microbiology. 13. 1174030–1174030. 10 indexed citations
9.
Liu, Kunpeng, Yun Peng, Zhe Ding, et al.. (2022). Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice. Virologica Sinica. 37(4). 581–590. 1 indexed citations
10.
Ding, Zhe, Tong Chen, Jiaming Lan, & Gary Wong. (2022). Application of animal models to compare and contrast the virulence of current and future potential SARS-CoV-2 variants. Biosafety and Health. 4(3). 154–160. 7 indexed citations
11.
Liu, Qixing, Zhe Ding, Jiaming Lan, & Gary Wong. (2021). Design of Replication-Competent VSV- and Ervebo-Vectored Vaccines Against SARS-CoV-2. Methods in molecular biology. 2410. 193–208. 2 indexed citations
12.
Yang, Ren, Jiaming Lan, Baoying Huang, et al.. (2020). Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections. EBioMedicine. 58. 102890–102890. 20 indexed citations
13.
Yao, Yanfeng, Huadong Wang, Jianjun Chen, et al.. (2019). Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine. Emerging Microbes & Infections. 8(1). 45–54. 12 indexed citations
14.
Deng, Yao, Jiaming Lan, Linlin Bao, et al.. (2018). Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus. Emerging Microbes & Infections. 7(1). 1–10. 39 indexed citations
15.
Deng, Yao, et al.. (2016). Serological Study of An Imported Case of Middle East Respiratory Syndrome and His Close Contacts in China, 2015.. PubMed Central. 29(3). 219–23. 11 indexed citations
16.
Wang, Wen‐Ching, Huijuan Wang, Yao Deng, et al.. (2016). Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China. Emerging Microbes & Infections. 5(1). 1–12. 17 indexed citations
17.
Liu, William J., Jiaming Lan, Kefang Liu, et al.. (2016). Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus–Derived CD8+ T Cell Epitopes and Host MHC. The Journal of Immunology. 198(2). 873–882. 38 indexed citations
18.
Yang, Yang, Yao Deng, Bo Wen, et al.. (2014). The Amino Acids 736–761 of the MERS-CoV Spike Protein Induce Neutralizing Antibodies: Implications for the Development of Vaccines and Antiviral Agents. Viral Immunology. 27(10). 543–550. 22 indexed citations
20.
Lan, Jiaming, Zhiyun Gao, Huabao Xiong, et al.. (2011). Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime–protein boost vaccination. Vaccine. 29(40). 6894–6902. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026